North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Dapagliflozin
found
10 matches
Open monograph to display formulary status
BNF Category
Dapagliflozin
(Forxiga
®
)
Cardiovascular system - SGLT-2 inhibitor - 02.15
Dapagliflozin
(Forxiga
®
)
Endocrine system - SGL2 inhibitors - 06.01.02.03
Links
Link to Drug Section
Link to document
NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (06.01.02.03)
NICE TA418: Dapagliflozin in triple therapy for treating type 2 diabetes (06.01.02.03)
NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction (02.15)
NICE TA775: Dapagliflozin for treating chronic kidney disease (06.01.02.03)
NICE TA902: Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (02.15)
